These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Development of a rhenium-186-labeled MAG3-conjugated bisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals. Ogawa K, Mukai T, Arano Y, Ono M, Hanaoka H, Ishino S, Hashimoto K, Nishimura H, Saji H. Bioconjug Chem; 2005 Sep; 16(4):751-7. PubMed ID: 16029015 [Abstract] [Full Text] [Related]
27. Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oil. Kumar A, Srivastava DN, Bal C. J Vasc Interv Radiol; 2006 Jan; 17(1):157-61. PubMed ID: 16415146 [Abstract] [Full Text] [Related]
28. Endoradiotherapy in cancer treatment--basic concepts and future trends. Zoller F, Eisenhut M, Haberkorn U, Mier W. Eur J Pharmacol; 2009 Dec 25; 625(1-3):55-62. PubMed ID: 19836381 [Abstract] [Full Text] [Related]
30. Labelling of Re-ABP with 188Re for bone pain palliation. Arteaga de Murphy C, Ferro-Flores G, Pedraza-López M, Meléndez-Alafort L, Croft BY, Ramírez FM, Padilla J. Appl Radiat Isot; 2001 Mar 25; 54(3):435-42. PubMed ID: 11214878 [Abstract] [Full Text] [Related]
39. Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides. Cremonesi M, Ferrari M, Bodei L, Tosi G, Paganelli G. Q J Nucl Med Mol Imaging; 2006 Dec 25; 50(4):288-95. PubMed ID: 17043626 [Abstract] [Full Text] [Related]